作者：
Olivier,Trédan [1]
;
Maud,Toulmonde [2]
;
Christophe,Le Tourneau [3]
;
Laure,Montane [4]
;
Antoine,Italiano [5]
;
Isabelle,Ray-Coquard [3]
;
Christelle,De La Fouchardière [1]
;
François,Bertucci [1]
;
Anthony,Gonçalves [6]
;
Carlos,Gomez-Roca [6]
;
Benoit,You [7]
;
Valéry,Attignon [8]
;
Sandrine,Boyault [9]
;
Philippe A,Cassier [9]
;
Armelle,Dufresne [1]
;
Séverine,Tabone-Eglinger [1]
;
Alain,Viari [10]
;
Emilie,Sohier [11]
;
Maud,Kamal [11]
;
Gwenaël,Garin [4]
;
Jean-Yves,Blay [5]
;
David,Pérol [1]
作者单位：
Medical Oncology Department, Centre Léon Bérard, 69008 Lyon, France.
[1]
Inserm U1052, Centre de Recherche en Cancérologie de Lyon, F-69000 Lyon, France.
[2]
Medical Oncology Department, Institut Bergonié, 33076 Bordeaux, France.
[3]
Department of Drug Development and Innovation (D3i), Institut Curie, Paris-Saclay University, 75005 Paris, France.
[4]
Department of Clinical Research and Innovation, Léon Bérard Cancer Center, 69008 Lyon, France.
[5]
Department of Medical Oncology, Institut Paoli-Calmettes, 13009 Marseille, France.
[6]
Medical Oncology Department, Institute Universitaire de Cancérologie de Toulouse, 31037 Toulouse, France.
[7]
Department of Medical Oncology, Lyon Sud Hospital Center, CITOHL, Institute of Cancerology, Hospices Civils de Lyon (IC-HCL), 69495 Lyon, France.
[8]
Genomic Platform, Léon Bérard Cancer Center, 69008 Lyon, France.
[9]
Biological Ressources Center, Léon Bérard Cancer Center, 69008 Lyon, France.
[10]
Gilles Thomas Bioinformatic Platform, Léon Bérard Cancer Center, 69008 Lyon, France.
[11]
DOI
10.3390/cancers15133441
PMID
37444551
发布时间
2023-07-18
换一批
换一批
